Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114873) titled 'Multi-omics cohort study on immune dynamics and early-warning prognostic biomarkers in sepsis' on Dec. 18, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Taizhou Central Hospital (Taizhou University Hospital)
Condition:
Sepsis
Intervention:
Healthy Control:Not available
Non-sepsis infection:Not available
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2025-05-22
Target Sample Size: Healthy Control:30;Non-sepsis infection:20;Sepsis:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.ht...